Italy
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -487.78 M
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
|
2 |
USD -423.03 M
|
Dec. 31, 2023 | USD 61.85 | 0.84% |
|
Italy |
|
3 |
USD -56.03 M
|
Dec. 31, 2023 | USD 9.97 | 0.35% |
|
Italy |
|
4 |
USD -50.18 M
|
Dec. 31, 2023 | USD 107.00 | 0.25% |
|
Italy |
|
5 |
USD -14.62 M
|
Dec. 31, 2023 | USD 53.58 | -1.47% |
|
Italy |
|
6 |
USD -6.12 M
|
Dec. 31, 2023 | USD 19.14 | -0.29% |
|
Italy |
|
7 |
USD -91.29 K
|
Dec. 31, 2023 | USD 1.99 | -0.79% |
|
Italy |
|
8 |
USD -15.22 K
|
Dec. 31, 2023 | USD 3.52 | -12.00% |
|
Italy |
|
9 |
USD -12.14 K
|
Dec. 31, 2023 | USD 10.86 | 4.76% |
|
Italy |
The Healthcare company in Italy with the highest Capital Expenditure is Stevanato Group S.p.A. (NYSE: STVN) at USD -487.78 M.
The Healthcare company in Italy with the lowest Capital Expenditure is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at USD -12.14 K.
The top 10 Healthcare companies in Italy by Capital Expenditure are Stevanato Group S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., GPI S.p.A., DiaSorin S.p.A., Pharmanutra S.p.A., Philogen S.p.A., Arterra Bioscience, Genenta Science S.p.A. and Newron Pharmaceuticals S.p.A..
The bottom 10 Healthcare companies in Italy by Capital Expenditure are Newron Pharmaceuticals S.p.A., Genenta Science S.p.A., Arterra Bioscience, Philogen S.p.A., Pharmanutra S.p.A., DiaSorin S.p.A., GPI S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A. and Stevanato Group S.p.A..